| dc.creator |
Iraz, M |
|
| dc.creator |
Yilmaz, HR |
|
| dc.creator |
Ozyurt, H |
|
| dc.creator |
Temel, I |
|
| dc.creator |
Gulec, M |
|
| dc.date |
2006-04-01T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:21:17Z |
|
| dc.date.available |
2021-12-03T11:21:17Z |
|
| dc.identifier |
4c7ea15f-3d01-46e5-bd26-f02813c6162f |
|
| dc.identifier |
10.1191/0748233705th255oa |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/4c7ea15f-3d01-46e5-bd26-f02813c6162f/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/91351 |
|
| dc.description |
This study was carried out to determine if Ginkgo Biloba Extract (GBE or Egb 761) exerts a beneficial effect against cisplatin-induced renal failure in rats. Sprague Dawley rats were divided into four groups. The first group (control) received orally 1 mL/kg/day of 0.9% saline by an oral carrier vehicle on days 1 to 10. The second group was injected with 7 mg/kg cisplatin intraperitoneally (i.p.) on the fourth day, once only. The third group (vit E + cisplatin) was administered 10 mg/kg/day i.p. vit E on 1 to 10 days with one dose of i.p. cisplatin (7 mg/kg) injection on the fourth day. The fourth group (GBE + cisplatin) was given GBE orally at 100 mg/mL/kg started on the first day up to the tenth day with one dose of cisplatin (7 mg/kg) injection on the fourth day. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
The effects of ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde, and nitric oxide in cisplatin-induced nephrotoxicity |
|
| dc.type |
info:eu-repo/semantics/article |
|